Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Swain

Showing results (371-380 of 532) with videos related to

Pageof 54
Sort By:
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Sandra M Swain, et al.
European Journal of Pharmacology|October 9, 2017
CO-independent modification of K<sup>+</sup> channels by tricarbonyldichlororuthenium(II) dimer (CORM-2)Guido Gessner, Nirakar Sahoo, Sandip M Swain, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2019
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe ObesityKelli A Lytle, Nikki C Bush, Jessica M Triay, et al.
Investigational New Drugs|August 26, 2006
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancerNeelima Denduluri, James J Lee, Janice Walshe, et al.
Pharmacogenomics|September 24, 2020
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testingD Max Smith, Tarlan Namvar, Ryan P Brown, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessmentScott G Houghton, Lana G Nelson, James M Swain, et al.
Obesity (Silver Spring, Md.)|February 19, 2013
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesityM M J Guichelaar, S Gawrieh, M Olivier, et al.
Research Square|December 11, 2023
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Pageof 54

Showing results (371-380 of 532) with videos related to

Sort By:
Pageof 54
Breast Cancer Research and Treatment|August 21, 2019
Pathologic complete response and outcomes by intrinsic subtypes in NSABP B-41, a randomized neoadjuvant trial of chemotherapy with trastuzumab, lapatinib, or the combinationSandra M Swain, Gong Tang, Peter C Lucas, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2004
A phase II trial of neoadjuvant docetaxel and capecitabine for locally advanced breast cancerPeter F Lebowitz, Jennifer Eng-Wong, Sandra M Swain, et al.
European Journal of Pharmacology|October 9, 2017
CO-independent modification of K<sup>+</sup> channels by tricarbonyldichlororuthenium(II) dimer (CORM-2)Guido Gessner, Nirakar Sahoo, Sandip M Swain, et al.
The Journal of Clinical Endocrinology and Metabolism|August 14, 2019
Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe ObesityKelli A Lytle, Nikki C Bush, Jessica M Triay, et al.
Investigational New Drugs|August 26, 2006
Phase II trial of ixabepilone, an epothilone B analog, given daily for three days every three weeks, in metastatic breast cancerNeelima Denduluri, James J Lee, Janice Walshe, et al.
Pharmacogenomics|September 24, 2020
Assessment of primary care practitioners' attitudes and interest in pharmacogenomic testingD Max Smith, Tarlan Namvar, Ryan P Brown, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|August 24, 2006
Is Roux-en-Y gastric bypass safe after previous antireflux surgery? Technical feasibility and postoperative symptom assessmentScott G Houghton, Lana G Nelson, James M Swain, et al.
Obesity (Silver Spring, Md.)|February 19, 2013
Interactions of allelic variance of PNPLA3 with nongenetic factors in predicting nonalcoholic steatohepatitis and nonhepatic complications of severe obesityM M J Guichelaar, S Gawrieh, M Olivier, et al.
Research Square|December 11, 2023
iGenSig-Rx: an integral genomic signature based white-box tool for modeling cancer therapeutic responses using multi-omics dataSanghoon Lee, Min Sun, Yiheng Hu, et al.
Pediatric Blood & Cancer|November 18, 2015
Characterization of MHC Class I and β-2-Microglobulin Expression in Pediatric Solid Malignancies to Guide Selection of Immune-Based Therapeutic TrialsKellie B Haworth, Michael A Arnold, Christopher R Pierson, et al.
Pageof 54